DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidcardiologyANOCAINOCAvasospastic-anginamicrovascular-anginacoronary-function

Vasospastic and microvascular angina

Essential points for quick revision.

!
Escalate

Treat new or prolonged rest pain with ECG change or troponin rise as possible ACS until excluded. Coronary spasm can cause infarction, syncope and ventricular arrhythmia and may require urgent monitored care.

Synopsis

Recognise angina with non-obstructive coronary arteries, identify vasospastic or microvascular endotypes and use mechanism-directed testing and treatment.

  • Non-obstructive coronary arteries do not make angina non-cardiac; consider epicardial spasm and coronary microvascular dysfunction.
  • Vasospastic angina often occurs at rest, particularly at night or early morning, with transient ST change and prompt nitrate response.
  • Microvascular angina may be exertional or occur at rest and can persist longer than classic obstructive angina.

Key red flags

High-risk spasm

Syncope, ventricular arrhythmia, infarction or prolonged ST elevation during an episode requires urgent monitored specialist management.

Investigation priorities

01
12-lead ECG during symptomsFirst step

Document transient ischaemic change or arrhythmia.

Management branches

Preferred routeAcute rest pain

Current severe or prolonged symptoms

  1. Use the ACS pathway with ECG, serial troponin, monitoring and urgent assessment; give sublingual GTN when safe.
  2. Treat persistent ST elevation, arrhythmia or haemodynamic compromise as an emergency.
Preferred routePersistent ANOCA or INOCA

Angina continues despite non-obstructive CTCA or angiography

Key medicines

Glyceryl trinitrate sublingual spray400–800 micrograms under the tongue at symptom onset; repeat at 5-minute intervals if needed, to a maximum total of 3 sprays, then seek prompt medical help if unresolved.
Amlodipine5 mg orally once daily, increased to 10 mg once daily according to response and tolerance.
Open full textbook Answer 2 questionsCardiology check
Sources and review status8 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom